Effect of Anagliptin versus Sitagliptin on Renal Function: Subanalyzes from the REASON Trial.

Hiroki Teragawa Takeshi Morimoto Yuichi FujiiTomohiro UedaMio SakumaMichio ShimabukuroOsamu ArasakiKoichi NodeTakashi NomiyamaShinichiro Ueda

Published in: Diabetes, metabolic syndrome and obesity : targets and therapy (2022)

These findings imply that the effects of DPP-4 inhibitors on renal function, especially on UACR, may be different between the types of DPP-4 inhibitors.

Keyphrases

clinical trial
study protocol
phase ii
open label